Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA)

M. Nieto Barbero (M, Spain), C. Vadillo (M, Spain), F. Pelaez (M, Spain), A. Palomar (M, Spain), L. Abasolo (M, Spain)

Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Session: Assessment and management of immune-mediated interstitial lung diseases
Session type: Thematic Poster
Number: 4742
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Nieto Barbero (M, Spain), C. Vadillo (M, Spain), F. Pelaez (M, Spain), A. Palomar (M, Spain), L. Abasolo (M, Spain). Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA). 4742

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020


Characteristics and predictors of outcome in rheumatoid arthritis related ILD
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013

The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA)
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016


Mortality and clinical features in rheumatoid arthritis and interstitial lung disease
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008

Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Source: Eur Respir J, 53 (1) 1800869; 10.1183/13993003.00869-2018
Year: 2019



Methotrexate and rheumatoid arthritis associated interstitial lung disease
Source: Eur Respir J, 57 (2) 2000337; 10.1183/13993003.00337-2020
Year: 2021



Lung diseases directly associated with rheumatoid arthritis and their relationship to outcome
Source: Eur Respir J 2011; 37: 1411-1417
Year: 2011



The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009


Destructive bronchiolitis: a characteristic pathological feature of interstitial lung disease preceding the onset of rheumatoid arthritis
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020


Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

The value of biomarkers in the rheumatoid arthritis related interstitial pneumonia
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013


Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017

Prevalence of pulmonary involvement in rheumatoid arthritis patients in Indian population
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013

Analysis of lung diseases associated with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 307s
Year: 2006

Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019

Duration of rheumatoid arthritis and the risk of developing interstitial lung disease
Source: ERJ Open Res, 7 (1) 00633-2020; 10.1183/23120541.00633-2020
Year: 2021



Genomic comparison of fibrotic rheumatoid arthritis-associated ILD and idiopathic pulmonary fibrosis
Source: International Congress 2015 – Connective tissue disorders
Year: 2015

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
Source: Eur Respir J 2010; 35: 1322-1328
Year: 2010



Analysis of inflammatory networks in interstitial lung disease in patients with rheumatoid arthritis
Source: International Congress 2016 – Connective tissue disorders
Year: 2016